Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition'

Abstract

From the beginning of this process, EASL, AASLD, and ALEH have been united in advancing the field for patients with steatotic liver disease. We recognize that the journey to consensus has been challenging and, as one might expect from a consensus process addressing a topic with numerous divergent opinions, not all individual perspectives and arguments can be accommodated.